Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

Swisher, Elizabeth M.; Kwan, Tanya T.; Oza, Amit M.; Tinker, Anna V.; Ray-Coquard, Isabelle; Oaknin Benzaquen, Ana Mazaltob

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Swisher, Elizabeth M.
dc.contributor.author	Kwan, Tanya T.
dc.contributor.author	Oza, Amit M.
dc.contributor.author	Tinker, Anna V.
dc.contributor.author	Ray-Coquard, Isabelle
dc.contributor.author	Oaknin Benzaquen, Ana Mazaltob
dc.date.accessioned	2022-01-20T14:13:30Z
dc.date.available	2022-01-20T14:13:30Z
dc.date.issued	2021-05-03
dc.identifier.citation	Swisher EM, Kwan TT, Oza AM, Tinker AV, Ray-Coquard I, Oaknin A, et al. Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2). Nat Commun. 2021 May 3;12:2487.
dc.identifier.issn	2041-1723
dc.identifier.uri	https://hdl.handle.net/11351/6853
dc.description	Càncer d'ovaris; Biomarcadors tumorals
dc.language.iso	eng
dc.publisher	Nature Research
dc.relation.ispartofseries	Nature Communications;12
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Ovaris - Càncer - Tractament
dc.subject	Ovaris - Càncer - Recaiguda
dc.subject.mesh	Ovarian Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Neoplasm Recurrence, Local
dc.title	Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41467-021-22582-6
dc.subject.decs	neoplasias ováricas
dc.subject.decs	/farmacoterapia
dc.subject.decs	recurrencia neoplásica local
dc.relation.publishversion	https://doi.org/10.1038/s41467-021-22582-6
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Swisher EM] University of Washington, Seattle, WA, USA. [Kwan TT] Clovis Oncology, Inc., Boulder, CO, USA. [Oza AM] Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. [Tinker AV] BC Cancer—Vancouver, Vancouver, BC, Canada. [Ray-Coquard I] GINECO, Centre Léon Bérard and University Claude Bernard, Lyon, France. [Oaknin A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid	33941784
dc.identifier.wos	000656508100001
dc.rights.accessrights	info:eu-repo/semantics/openAccess